TP53 was the most frequently mutated gene locus with alterations noted in 46.1% of tumor samples (12 of 26), followed by KRAS mutations (9 of 26, 34.6%) and BRCA2 mutations (6 of 26, 23.0%). The gene discussed is BRCA2; the disease is neoplasm.